Klebsiella pneumoniae is a common hospital-acquired pathogen, causing urinary tract infections, nosocomial pneumoniae, and intra-abdominal infections. K.pneumoniae is also a potential community acquired pathogen. The aims of this study are to determine epidemiology of ESBL-producing K.pneumoniae and K.oxytoca in Iran during different seasons, to determine the prevalence of blaTEM, SHY and CTX-M responsible for ESBL production among ESBL-producing K.pneumoniae and K.oxytoca in the different wards and hospitals in Iran. Klebsiella spp producing ESBLs were identified by phenotypic and genotyping methods. The findings in this study revealed that 36.5%, 51.7% and 45.6% of K.pneumoniae were producing ESBLs in Ham, Milad and Emam Reza hospitals, respectively. The results revealed blaSHV was responsible for ESBLs production. The analysis showed significant difference ofESBLs production by K.pneumoniae in winter (53%) in comparison to the other seasons P':E. 0.01. The results also showed a significant difference in blaSHV that was the dominant gene responsible for ESBL production P':E. 0.049 but no significant difference was observed between blaTEM and blaSHV. The results showed that the highest ESBL production was found in K.oxytoca isolated from patients in Emam Reza Hospital and the lowest frequency of ESBL production was found among K.oxytoca in Ham hospital. BlaSHV was found as dominant gene responsible for ESBLs production by K.pneumoniae and K.oxytoca, followed by blaCTX-M.
which lead to the development of resistance to cephamycins and other antimicrobials (3) (4) (5) .
The plasmids that harbor genes encoding ESBLs frequently contain other genes encoding mechanisms of resistance to aminoglycoside and cotrimoxazole (6) . It is important to study the prevalence of Klebsiella spp in Iran, a four-season country. Klebsiella spp are frequently isolated in the winter season and responsible for the majority of nosocomial infections.
The aims of this study are to determine epidemiology of ESBL-producing Kpneumoniae and Koxytoca in Ham, Milad and EmamReza hospitals during different seasons, to identify the prevalence ofESBLs producing Kpneumoniae and Koxytoca in Ham,Milad Emam and Reza hospitals during different seasons, to determine the prevalence ofblaTEM, SHY and CTX-M responsible for ESBL production among ESBL-producing Kpneumoniae and Koxytoca in the different wards and hospitals in Iran.
MATERIALS AND METHODS

Bacterial isolates
Six hundred and seven clinical isolates of Klebsiella spp were identified during the period of March 2007 to April 2008 in three hospitals in three cities (Ham, Tabriz and Tehran) in Iran (Table I) . Klebsiella spp were identified by standard laboratory methods (7) .
Standard disc diffusion method: In-vitro sensitivity testing was performed using established CLSI (20 I0) procedure with ceftazidime (Ca) (30 ug), cefotaxime (Ce) (30 ug), ceftriaxone (Ci) (30 ug), azteronam (Ao) (30 ug) and cefpodoxime (Cep) (30 ug).
Phenotypic confirmatory method: Ceftazidime (30 ug) versus ceftazidime/c1avulanic (Cac) (30/1 0 ug), cefotaxime (30 ug) versus cefotaxime /c1avulanic acid (Cec) (30/10 ug) and cefpodoxim versus cefpodoxim / c1avulanic acid (Cep) (30/10 ug) were placed onto a Muller-Hinton agar plate lined with the test organism and incubated as described above. Regardless of the zone diameters, a > 5 mm increase in a zone diameter for an antimicrobial agent tested in combination with c1avulanic acid versus its zone size when tested alone, indicated a probable ESBL production (8) . Kpneumoniae ATCC 700603 was used as a control for ESBL tests.
The antibiotic susceptibility pattern of the ESBLproducing isolates to a panel of antibiotic drugs including: amikacin (30 ug), ciprofloxacin (30 ug), cotrimoxazol (30 ug) and imipenem (30 ug), was recorded by using the disk diffusion method (9) .
DNA was extracted using the DNA extraction KIT (Fermentas).
Polymerase Chain Reaction (PCR)
The polymerase chain reaction (PCR) was carried out by using primers in Table II .
Statistical analysis
Chi-square test by SPSS 16 was used with appropriate correction for the observation and for the significance between the ESBLs production during different seasons and units of hospital. P:S 0.05 was considered significant. Table I . The analysis showed high prevalence of K pneumoniae in UTI followed by RTI (P < 0.033). The percentage of Koxytoca in different hospitals and different parts of the hospitals is shown in Table I . Significant difference was observed in Koxytoca in RTI (P < 0.003), however, no significant difference occurred in the other units of hospitals (P:::: 0.05).
RESULTS
The analysis showed significant difference of ESBL production by Kpneumoniae in winter (53%) in comparison to the other seasons (P :::: 0.01). Kpneumoniae producing ESBLs was detected more in RTI with P :::: 0.03 (Fig. 2) .
The results also revealed significant difference among blaSHV that was the dominant gene responsible for ESBL production (P :::: 0.049) but no significant difference was observed in blaTEM and blaSHV ( Fig. 3 ).
ILAM HOSPITAL Kpneumoniae
Of the two hundred and eight clinical isolates of K pneumoniae collected from Ham hospital, 52.4% (n=109), 10.09% (n=2l), 7.7% (n=16), 11.06% (n=23) and 18.75% (n=39) were from UTI, ICUs, surgery ward, lesion ward and RTI, respectively. Therefore, the highest K pneumoniae isolates were isolated in UTI (P < 0.04). In this study, generally 58.3%, 43.9%, 58.1%, 46% and 44.7% of the isolates were resistant to ceftazidime, cefotaxime, cefteriaxon, cefpodoxime and aztreonam, respectively (Table III) . Confirmation ofCac, Cec and Cepe were 31.7%, 8.7% and 36.5% respectively. In addition, results revealed that significant confirmation occurred among Cepe. The results reflected 36.5% (n=76) of the isolates were ESBL-positive. Significant difference was observed in cefteriaxone resistance (P <0.045).
Of the seventy-five Kpneumoniae producing ESBLs, 7.9% were resistant to amikacin, 4% to ciprofloxacin and 12%, to cotrimoxazol. This analysis showed resistance to non-beta-lactam antibiotics among Kpneumoniae producing ESBLs. The results showed resistance to cotrimoxazol more than in the others.
No significant difference occurred in resistance toward non-beta-lactam antibiotics in Ham hospital (P~0.05).
rc« results
Sixty-two Kpneumoniae with blaSHV were obtained in this study, of which 52% (n=32), 3.2% (n=2), 9.8% (n=6), 14.5% (n=9) and 21.3% (n=13) were from patients with UTI, patients in ICUs and surgery wards, patients with lesion infections and patients with RTI, respectively. The results also showed that of the ten Kpneumoniae with blaTEM, 80% (n=8), 10% (n=l) and 10% (n=l) were from 16 .67% (n=2) and 66.66% (n=8) were from patients admitted to surgery wards, patients with lesions and resp iratory tract infections, respectively ( Fig . 4 ). Generally, resistance to ceftazidime, cefotaxime, cefteriaxone, cefpodoxime and aztreonam were 41.66%, 16.66%,33 .3%,25% and 25%, respectively (Table III) . Among those resistant to cephalosporins, K oxytoca were found to be the most resistant toward ceftazidime (P < 0.049).
The resu lts showed that all Koxytoca producing ESBL s were susceptible to non-beta lactam antibiotics.
PCR results
Three Koxytoca producing ESBLs were found in the phenotypic stages, which were positive for 
MILAD HOSPITAL
Two hundred and sixty-five Kpneumoniae and fifteen Koxytoca were obtained from two hundred and eighty Klebsiella spp (Fig. 1) . Kpneumoniae
In this study, generally, 65.8%, 46.4%, 60.4%, 52% and 51.7% of the isolates were resistant to ceftazidime, cefotaxime, cefteriaxon, cefpodoxime and aztreonam, respectively (Table III peR results Of the one hundred and twenty Kpneumoniae with blaSHV, 47.5% (n=57) , 9.1% (n=ll), 9.1% (n= I I), 6.7% (n=8) and 27.5% (n=33) were from patients with urinary tract infections, patients admitted to lCUs , surgery ward , patients with lesion infections and patients with respiratory tract infections, respectively. The highest prevalence of blaSHV occurred in UTI (P < 0.002).
Of the seventeen Kpneumoniae with blaTEM, 23.5% (n=4), 11.7% (n=2), 11.7% (n=2), 5.9% (n=l) and 47% (n=8) were from patients with UTI, patients admitted to ICUs, surgery ward, patients with lesion infections and patients with RTIs, respectively. Significant difference of prevalence of blaTEM was observed in RTI (P < 0.04).
Ofthe thirty-four Kpneumoniae with blaCTX-M, 41.2% (n=14), 11.8% (n=4), 11.8% (n=4), 5.9% (n=2) and 29.5% (n=lO) were obtained from patients with UTI, in ICUs, in surgery ward, patients with lesions and respiratory tract infections, respectively. The highest prevalence of blaCTX-M occurred in UTI (P < 0.005) ( Fig. 3) .
Koxytoca
The results showed that fifteen clinical isolates of Koxytoca were obtained in the surgery ward, from patients with lesion and respiratory tract infections. It was found that 40% (n=6) and 27.3% (n=3) of Koxytoca producing ESBLs were resistant to cotrimoxazol and amikacin, respectively. Resistance to the other non-beta lactam antibiotics were not observed. The findings showed 73.3% of Kioxytoca produces ESBLs. The analysis of data also showed that there was no significant difference between seasons and ESBL production (P 2: 0.05).
PCR results
Of the eleven Koxytoca producing ESBLs at the phenotypic stage, 100% (n= 11) blaSHV were obtained by the PCR method. The results that showed blaTEM and blaCTX-M were negative.
EMAM REZA HOSPITAL Kpneumoniae
Of the one hundred and three clinical isolates of Kpneumoniae collected in Emam Reza Hospital, Tabriz, 43.69% (n=45), 13.59% (n=14), 7.77% (n=8), 11.65% (n=12) and 23.3% (n=24) were from UTI, ICUs, surgery wards, lesion infections and RTI, respectively (Fig. 4) .
Generally, 57.3%, 38.8%, 62.1%, 45.6 and 43.7% of Kpneumoniae showed resistance to ceftazidime, cefotaxime, cefteriaxone, cefpodoxime and azteronam, respectively (Table III ). The results showed that 43.7% of isolates produce ESBLs.
Significant difference was observed in Kpneumoniae resistance to cefteriaxone (P < 0.34).
The results showed that 26.7%, 6.7%, 20% and 0% of Kpneumoniae producing ESBLs were resistant to amikacin, ciprofloxacin, cotrimoxazol and imipenem, respectively.
PCR results
Of the thirty-nine Kpneumoniae with blaSHV, 38.5% (n=15), 18% (n=7), 5.1% (n=2), 5.1% (n=2) and 33.3% (n=13) were from patients with UTI, patients in ICUs, surgery wards, patients with lesion infections and patients with RTIs, respectively. Of the seven Kpneumoniae with blaTEM, 71.4% (n=5), 14.3% (n=l) and 14.3% (n=l) were obtained from the patients with UTI, patients in ICUs and patients with RTIs, respectively. Of the seven Kpneumoniae with blaCTX-M, 57.1% (n=4), 14.3% (n=I), 14.3% (n= 1) and 14.3% (n=1) were from patients with UTIs, patients in ICUs, surgery wards and the patients with RTIs, respectively (Fig. 3) .
Koxytoca
Of the four Koxytoca collected in Emam Reza Hospital, 25% (n=l) and 75 % (n=3) were from the surgery wards and RTI, respectively (Fig. 4) . The findings showed that 75% of Koxytoca were producing ESBLs. No significant difference was observed between seasons and antibiotic resistance (P 2: 0.05).
DISCUSSION
To the best of our knowledge, this study is the first to cover different seasons and hospital units all at once. Our findings showed that the highest ESBL production was found in Koxytoca isolated from patients in Emam Reza Hospital, Tabriz, and the lowest frequency ofESBL production was found in Koxytoca in Dam hospitals. In Ham hospitals, ESBLs production was observed to be more in Kpneumoniae (36.5%) while in Milad and Emam Reza hospitals the percentage of Koxytoca was higher than Kpneumoniae. The prevalence ofESBL production by Kpneumoniae in Milad Hospital was dominant (51.7%), followed by Emam Reza Hospital (45.6%). The most resistance to third-generation of cephalosporins was reported in Milad Hospital (64.1 % for ceftazidime).
Frequency of blaSHV was higher than the other genes responsible for ESBLs production. The most blaSHV were obtained in Milad Hospital while blaSHV was found to be more in Ham hospitals than in Emam Reza Hospital. These results recurred for blaCTX-M while in limn hospitals, more blaTEM were observed. Generally, ESBLs production in winter was higher than in the other seasons. Our findings also showed winter as a dominant season for resistance to non-beta-Iactam antibiotics.
This study was carried out in different seasons to find the relationship between seasons and the prevalence of infection in different units of hospitals. The use of antibiotics in Iran is uncontrollable and up to now the use of antibiotics and injectable formulations is high in the Islamic Republic of Iran. The large number of prescriptions for antibiotics (58% on average) may be because in the majority of the provinces, the data collected only covered a period of 1 winter month (12) . These findings showed a high level of antibiotic resistance, especially, for third-generation of cephalosporins. Interestingly, we found Imipenem to be effective in this study and could still be used for treatment. However, our findings revealed the urgency for controlling irregular consumption of antibiotics in Iran.
Although many international studies have addressed the emergence of ESBL-producing Kpneumoniae, there are a few reports on this issue from Iran. The current study demonstrated a very high prevalence of ESBL production by K pneumoniae isolates in all hospitals. This high ESBL frequency may have been caused by the excessive use of broad-spectrum antibiotics in all hospitals and to a higher level in the community setting, together with a lack of attention to laboratory screening of ESBL production by clinical isolates. Actually, ceftriaxone, and ceftazidime was the most common antibiotic in the hospital, as observed during this study. On the other hand, the high rate of ESBL production could possibly be due to the spread of one single clone or plasmid within the hospitals.
The prevalence of ESBLs among clinical isolates varied in different hospital in Iran, the highest prevalence was observed in Milad hospitals (51.6%) follow by Emam Reza (43.7%) and Ham hospitals (36.5%). The findings showed that the highest ESBL production was found in Koxytoca isolated from patients in Emam Reza Hospital, Tabriz, and the lowest frequency of ESBL production was found in Koxytoca in lIam hospital.
In a study carried out in Brazil at two tertiarycare teaching hospitals, from August 2003 to August 2004 (13) , 24.1 % K oxytoca producing ESBLs were found through phenotypic assays. This is lower than all the hospitals studied in this research.
Kpneumoniae isolates with an ESBL phenotype were more prevalent in Latin America (45.4%), followed by the Western Pacific region (24.6%), Europe (22.6%), the United States (7.6%) and Canada (4.9%), the results of this study showed high prevalence ofESBL production in all hospitals, whereas Ham and Emam Reza hospitals were close to Latin America and Milad hospital had a higher prevalence in comparison with the others. In the Middle East, where Iran is located, prevalence of ESBL-producing Kpneumoniae is as follows: Saudi Arabia 12.2% (14) , Lebanon 20.0% (15), Egypt 37.5% (16), Turkey 50.0% (17) and Jordan 80% (18) . The findings of this study showed ESBL production in Iran was more than Saudi Arabia 12.2%, Lebanon 20.0% and Egypt 37.5%, but it was near to Israel and Turkey while it was lesser than Jordan.
Kpneumoniae isolates, even those producing ESBL, were reported to be 100% sensitive to imipenem by different research groups (19) . Many investigators prefer imipenem and meropenem as the drugs of choice for life-threatening infections due to ESBL-producing Enterobacteriaceae or in an outbreak setting (20) .
In a study in Milad Hospital in Tehran, carried out between March and June 2009, of the one hundred and fifteen strains of Kpneumoniae from urine specimens, 12% isolates of Kpneumoniae were found positive for ESBLs (21) . The results showed a decline in ESBL production in UTI compared with our findings a year ago in Milad Hospital (50.7%).
Further studies are required to investigate ESBL production and antimicrobial pattern, using more isolates from other parts of Iran. According to the results of this study, most Kpneumoniae were isolated from the urinary and respiratory tract infections. Generally, in the cold months, resistance to third-generation of cephalosprins was higher than during the warm months. Furthermore, resistance to cefpodoxime was almost equal to that of azteronam, while resistance to other cephalosprins, used in this study, varied considerably. Studies of molecular epidemiology of these resistance genes could also be used for comparison with genes already isolated from other parts ofIran and the world. This study shows that Klebsiella recovered from clinical specimens in our study produce a higher number of ESBLs. Our study also showed resistance towards flouroquinolones, aminoglycosides and cotrimoxazole.
Carbapenems are the drugs of choice against infections caused by Klebsiella spp. Further molecular studies should be conducted to know the basis of ESBL production. Strict antibiotic policy should be adopted in hospitals to estimate the impact of higher resistance in bacteria and to take steps for reducing these resistances.
Kpneumoniae was more prevalent than Koxytoca, however ESBL production was seen more in Koxytoca. Kpneumoniae was isolated more in Milad hospital followed by Emam reza and Ham hospitals. ESBL producing isolates were isolated more in winter than in the other seasons. For screening stage, cefpodoxime was found to be effective as recommended by CLSI. In Iran among the isolates studied blaSHV was the dominant gene responsible for ESBL production. Among non-beta lactam antibiotics, imipenem showed 100% susceptibility followed by ciprofloxacin, cotrimoxazol and amikacin. MLST data showed Clonal complex I as dominant clone, however polyclonal spread of Kpneumoniae producing ESBLs was observed in the Milad hospital.
The recommendations of this study are: i) using the data as strategic tool to have an effective infection control measure; ii) intensive surveillance during winter and a good infection control team to regularly monitor nosocomial infection.
